Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening
A meta-analysis of 56 accuracy studies and 25 randomised trials found that self-sampled swabs tested with PCR detect precancer as well as clinician-taken samples, and mailing kits to under-screened women roughly doubles participation.
Arbyn and colleagues pooled diagnostic accuracy studies comparing HPV testing on self-collected versus clinician-collected samples, and randomised trials comparing strategies to reach under-screened women.
With PCR-based assays, sensitivity for CIN2+ and CIN3+ on self samples was equivalent to clinician samples (relative sensitivity 0.99) and specificity was marginally lower (0.98). Signal-amplification assays performed worse on self samples. Mailing self-sampling kits to all under-screened women increased participation more than twofold compared with an invitation letter, as did door-to-door offers; opt-in kits produced smaller gains.
The findings underpin WHO and national guidance that self-sampling is an acceptable primary screening method.
- PCR-based assays: pooled relative sensitivity of self vs clinician samples 0.99 for CIN2+, relative specificity 0.98
- Signal-amplification assays were less sensitive on self samples (relative sensitivity 0.85 for CIN2+)
- Mailing kits to under-screened women increased participation about 2.3-fold versus invitation letters
- Opt-in approaches (women must request a kit) gave only modest participation gains
Women can collect their own screening sample at home with no loss of accuracy if the laboratory uses a PCR test. Sending kits directly is the most effective way to reach women who do not attend, which matters because most cervical cancers occur in under-screened women.
- Accuracy equivalence holds only for PCR-based assays validated for self samples
- Triage of positive self-samples still requires a clinic visit; follow-up completion is the weak point
- Participation trials were heterogeneous in setting and delivery
- Self-sampling for cytology (rather than HPV) is not supported
Pages like this
not linked directly; found by shared links- PersonJade Goody
Shares HPV DNA testing and self-sampling, HPV & HBV vaccination, Prevention we already have is not deployed, Most lethal cancers are found late.
- Key paperEngland's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13
Shares HPV DNA testing and self-sampling, HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
- IdeaSingle-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries
Shares HPV DNA testing and self-sampling, HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
- PersonPartha Basu
Shares HPV DNA testing and self-sampling, HPV & HBV vaccination, Cervical cancer.
- IdeaEliminate infection-caused cancers: HPV, hepatitis B and C, H. pylori and EBV
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.
- IdeaSwitch every country to single-dose HPV vaccination and add catch-up to age 26
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.
- Key paperSwedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17
Shares HPV DNA testing and self-sampling, HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
- IdeaOffer HPV vaccination to women when they come for cervical screening or treatment
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Cervical cancer.